49 results
424B1
VVOS
Vivos Therapeutics Inc
26 Apr 24
Prospectus with pricing info
5:07pm
condition, results of operations, business strategy and financial needs. These forward-looking statements include statements relating to:
our ability
8-K
EX-99.1
VVOS
Vivos Therapeutics Inc
28 Mar 24
Vivos Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Operational Update
8:38pm
with Lincare, and marks an important milestone in Vivos’ strategy to engage with leading durable medical equipment (DME) companies in the United States
424B1
grfhd6kzjxzzrv6
1 Dec 23
Prospectus with pricing info
4:12pm
PRE 14A
zrd0z0xmfnrcv
16 Aug 23
Preliminary proxy
4:45pm
8-K
EX-99.1
5m7jex6j3fogzyby
20 Dec 22
Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update
4:15pm